Green Lane, PA, United States of America

Kenneth A Krammer

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth A Krammer. Retrieved from https://idiyas.com/inventor/kenneth-a-krammer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth A Krammer: Innovator in Pharmaceutical Composition

Introduction

Kenneth A Krammer is a notable inventor based in Green Lane, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on drug compositions.

Latest Patents

Kenneth A Krammer holds a patent for a pharmaceutical composition that combines enalapril and losartan with a pharmaceutically acceptable carrier. This invention aims to enhance the efficacy of these medications in treating various health conditions.

Career Highlights

Kenneth is associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to focus on developing advanced pharmaceutical solutions that benefit patients worldwide.

Collaborations

Throughout his career, Kenneth has collaborated with esteemed colleagues, including Tzyy-Show H Chen and Charles S Sweet. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Kenneth A Krammer's contributions to pharmaceutical compositions exemplify the impact of innovation in healthcare. His work continues to influence the development of effective treatments for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…